Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Total Stock Market ETF (NY:VTI)

305.28 -2.75 (-0.89%)
Streaming Delayed Price Updated: 12:25 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Total Stock Market ETF

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
64 65 Next >
After Meeting With Jane Fraser, Wells Fargo Reiterates Citi As Top Bank Pick
According to TheFly, Wells Fargo analyst Mike Mayo stated that Citi is on the cusp of transitioning from value destruction to value creation, noting that the stock should rise above its tangible book... 
Via Stocktwits
Topics Economy Government
Regeneron To Buy Licensing Rights For China-Developed Investigational Obesity Drug For $2B: Retail Sees Stock Hitting $500
Separately, Regeneron on Monday also announced positive interim data from its ongoing Phase 2 trial investigating novel combinations of semaglutide and Trevogrumab with or without garetosmab for the... 
Via Stocktwits
Topics Death
Applied Digital Stock Rockets 40% After $7B Deal With CoreWeave: Retail’s Exuberant
The agreements, each spanning roughly 15 years, will enable Applied Digital to deliver 250 megawatts of critical IT power to support CoreWeave’s AI and HPC systems at its data center complex in... 
Via Stocktwits
Topics Artificial Intelligence
JetBlue Dismisses Merger Talk After Deal With United, Says Report: Retail Shares The Conviction
JetBlue CEO Joanna Geraghty confirmed the alliance will not lead to a merger, citing caution after years of scrutiny from the Department of Justice. 
Via Stocktwits
Topics Artificial Intelligence
Wall Street Strategists Warn S&P 500’s Momentum Could Unravel Under Stagflation Pressure, Tariff Concerns
JPMorgan strategist Mislav Matejka warned that the current tariff landscape is more severe than many had anticipated earlier in the year. 
Via Stocktwits
Topics ETFs Economy Government
Microsoft Commits $400M To Boost Swiss AI, Cloud Ecosystem: Retail Mood Stays ‘Bearish’
Microsoft will expand AI infrastructure, support startups, and train one million Swiss citizens in digital skills by 2027. 
Via Stocktwits
Topics Artificial Intelligence
Google Isn’t Backing Down: Alphabet Says Antitrust Court Got It Wrong Over Search Monopoly, Vows To Fight Verdict
District of Columbia Judge Amit Mehta heard the closing arguments on the case on Friday, with the final ruling expected by August. 
Via Stocktwits
Topics Artificial Intelligence
Trump Media Secures $2.5B for Bitcoin Treasury: But Retail’s Cautious
The transaction involved the sale of over 55.85 million common shares at $25.72 each, resulting in gross proceeds of approximately $1.44 billion. 
Via Stocktwits
Topics Government
EXL Expands Alliance With Databricks to Boost GenAI Migration Tools: But Retail Remains Cautious
The GenAI-powered tool will automate SAS code migration, reduce manual effort, and accelerate cloud modernization across various industries. 
Via Stocktwits
Topics Artificial Intelligence
Trump To Rally In Pittsburgh With US Steel-Nippon Deal Nearing Decision
Trump is set to deliver his remarks at 5 p.m. ET on Friday at a U.S. Steel facility in Pennsylvania, a key swing state he carried in the 2024 election. 
Via Stocktwits
Topics Government
EOG Resources To Acquire Encino Acquisition Partners For $5.6B
EOG said it expects to fund the acquisition through $3.5 billion of debt and $2.1 billion of cash on hand. 
Via Stocktwits
Topics Economy Energy
Gilead Eyes HIV Drug Rollout In Low-Income Countries Despite Funding Uncertainty, Says Report: Retail Holds Onto Bearish Stance
Gilead Chief Commercial Officer Johanna Mercier told Reuters that the company is eyeing a “global approach" to the launch of Lenacapavir. 
Via Stocktwits
Topics Government
Summit Therapeutics Stock Tumbles On Oncology Drug Trial Data, Retail Flags ‘Insane’ Valuation
Summit now intends to file a Biologics License Application (BLA) with the U.S. Food and Drug Administration seeking approval for Ivonescimab plus chemotherapy based on the results of the trial. 
Via Stocktwits
Topics Lawsuit Regulatory Compliance
Rigetti Stock Declines On $350M Share Sale: Retail Thinks ‘Dip’ Isn’t Worth Buying
Following Rigetti’s announcement, retail sentiment around Rigetti on Stocktwits dipped into the ‘bearish’ territory from ‘bullish’ the previous day. 
Via Stocktwits
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up
The offer price of $0.85 represents a discount of about 17% from the stock’s closing price on Thursday. 
Via Stocktwits
Zscaler Stock Draws Wall Street Praises Post Strong Q3 Print: Retail Joins The Party
While most analysts raised price targets, citing solid execution, growing demand, and AI potential, some remain cautious about leadership changes and sales strategy shifts. 
Via Stocktwits
Topics Artificial Intelligence
Wall Street Boosts Dell Price Targets on AI Surge Despite Mixed Q1 Results: Retail Confidence Jumps
Analysts cited strong AI momentum, including $12.1 billion in orders, that offsets macro pressures. 
Via Stocktwits
Topics Artificial Intelligence
Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge
Zymeworks is entitled to receive a $20 million milestone payment in connection with the NMPA approval of zanidatamab as part of its agreement with BeOne Medicines. 
Via Stocktwits
Hormel Foods Trims Full-Year Forecast On Tariff Pressures: Retail Mood Neutral
he company is known for its products such as Planters peanuts, Spam canned meat, and Skippy peanut butter. 
Via Stocktwits
Topics World Trade
Zscaler Stock Gains On Beat-and-Raise Q3 Amid Rising AI Security Needs: Retail Doubles Down On This Safe Bet
CEO Jay Chaudhary said demand for its “Zero Trust Exchange” cybersecurity platform continued to increase. 
Via Stocktwits
Topics Artificial Intelligence
Starbucks Takes Another Hit As TD Cowen Joins Goldman Sachs In Downgrading Stock: Retail Stays Bearish
The investment firm said its model predicts weak earnings from 2026 to 2028. 
Via Stocktwits
Dell Retail Traders Shrug Off Q1 EPS Miss As ‘Unprecedented’ AI Server Demand, Cheap Valuation Allay Concerns
The company generated $12.1 billion in AI orders in the quarter alone, surpassing the total number of shipments in FY25. 
Via Stocktwits
Topics Artificial Intelligence Earnings World Trade
Gap Warns Over $100M Impact From Tariffs Despite Mitigation Efforts: Retail Optimistic After Healthy Q1
The brand forecasted an 8-10% growth in operating profit in fiscal 2025, notwithstanding the impact of tariffs. 
Via Stocktwits
Topics World Trade
American Eagle Reports Wider-Than-Expected Loss, Downbeat Forecast: Retail Bullish After Stock's Slide
The results show that the brand continues to lose its appeal among consumers. 
Via Stocktwits
Ulta Beauty Bets Skincare Routines Will Remain Sacred Through Economic Strains — And Retail Traders Are Fully Onboard
The company beat expectations for its first-quarter results and raised its full-year outlook. 
Via Stocktwits
Estee Lauder Gets New Makeup Division Head, Price Target Boost: Stock Climbs, But Retail Unmoved
Lisa Sequino will oversee brands such as MAC, Bobbi Brown, Too Faced, Smashbox, and Glamglow. 
Via Stocktwits
Nvidia To $200? Jim Cramer Thinks These 2 Catalysts Could Do It
Sovereign artificial intelligence, a term coined by the company, has been one of its key focus areas in the recent quarters. 
Via Stocktwits
Topics Artificial Intelligence Earnings Government
AI Demand Powers Chipmaker Marvell’s Q1 Outperformance But Stock Drops: Retail Keeps Faith
CEO Matt Murphy said he sees the company’s custom silicon business driving strong growth in the second quarter and beyond. 
Via Stocktwits
Topics Artificial Intelligence
Powell Meets Trump, Stresses Monetary Policy Decisions Will Be Based On Objective And ‘Non-Political Analysis’
During his meeting with the U.S. President, the Fed Chair emphasized that the direction of monetary policy will depend entirely on incoming economic data and its implications for the outlook. 
Via Stocktwits
Topics ETFs Economy Government
Merck, Daiichi Sankyo Pull FDA Application For Lung Cancer Therapy: Retail Terms It A ‘Huge Flop’
The decision is based on results from a late-stage trial in which the drug failed to prolong patients' lives, the companies stated. 
Via Stocktwits
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.